[b]TNIB >> Investment Highlights[/b]
HTTP://WWW.SHAKERZANDMOVERZ.COM
Chart forming a bottom with increasing volume
Signs Memorandum of Agreement to Open Pharmaceutical Plant for the Production of IRT-103 (LDN)
Patents filed in China and expected to be filed in USA
Patents and the clinical trials include over 20 years of data
Targeted areas:
Autoimmune states such as rheumatoid arthritis and multiple sclerosis
As an adjunct to antibiotics in the treatment of infectious diseases
In cancer patients undergoing chemotherapy, radiation treatments or surgery
Patients with AIDS, in combination with retroviral drug therapy
In wound healing or herpes viral infections
Symbol is TNIB
News Link: http://finance.yahoo.com/q?s=tnib&ql=1
Please review the videos and articles related to immunotherapy, cancer treatments, and other related topics.
MENK Clinical Trials
MENK Articles
MENK Studies
LDN Clinical Trials
LDN Articles
LDN Studies
Company Overview
TNI BioTech Inc. is a biotech company combating fatal diseases through the activation and mobilization of the body’s immune system using our patented immunotherapy.
Our products and technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS and autoimmune diseases. We have been developing active and adaptive forms of immunotherapies.
Our proprietary technology, therapies and patents, will be used to treat a wide range of cancers. Our most advanced clinical programs involve immunotherapy that works by isolating a patient’s lymphocytes and then incubating them together with Methionine Enkephalin (MENK) in an enriching external incubation system. After incubation the patient’s lymphocytes are reinfused back into the patient where they combat and destroy tumor cells.
TNI BioTech Products
IRT-101 is an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells. This is accomplished by increasing the number of T cells and NK cells, NKT and Gammadelta T cells that destroy infective organisms and tumor cells while simultaneously inhibiting Treg cells.
IRT-102 is an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells and following an enriching external incubation are transfused back into the patient thereby providing the patient with a passive immunity containing large amounts of auto-amplified immune cells that combat cancer cells.
IRT- 103 is an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells. This is accomplished by activating the enkephalin receptor system resulting in increased number of T cells and NK cells that destroy infective organisms and tumor cells.
However, since any condition that results in an altered-immune response is a potential target for investigation. The Company intends to investigate the following valuable candidates:
Autoimmune states such as rheumatoid arthritis and multiple sclerosis.
As an adjuvant to vaccines in the protection from getting infectious diseases
In patients undergoing chemotherapy or radiation treatments in surgery
In wound healing, herpes and shingles in the elderly.
In clinical trials the evidence is significant that LDN/MENK stimulates the immune system and that it is effective in the treatment of some immune-suppressed diseases. The treatment modality has been demonstrated to be effective while avoiding certain deleterious effects on the body, as is often the case with traditional chemotherapy. The costs are reasonable, making this an attractive complement for a large number of cancer patients
Global Investment Media
310-353-6277
Investor Relations
Marlin Molinaro
Marmel Communications, LLC
702-434-8692
Website: http://www.tnibiotech.com/
TNI BioTech, Inc. Signs Memorandum of Agreement to Open Pharmaceutical Plant for the Production of IRT-103 (LDN)Marketwire(Tue 7:48AM EDT)
Dr. Ronald Herberman Joins TNI BioTech Inc. as Senior Vice President of Research and Development and Chief Medical OfficerMarketwire(Thu, Sep 6)
TNI BioTech, Inc. Acquires Portfolio of Exclusive Licenses to the Portfolio of Patents of Dr. Bernard BihariMarketwire(Tue, Aug 28)
TNI BioTech, Inc., in Partnership With GB Oncology and Imaging Group LTD., Signs Agreement With the Republic of MalawiMarketwire(Tue, Aug 7)
TNI BioTech, Inc. Announces Memorandum of Agreement With GB Oncology and Imaging Group LTDMarketwire(Tue, Jul 24)
TNIB Investment Highlights
Top 10 Most Recent News Articles
Eric Dalton: Redefining Homecare with Vision and Strategy
What's Behind Eric Dalton's Continued Recognition? Now, if you told me a healthcare leader’s named 'Visionary of the Year' twice in a row, my first thought isn't 'stretch goals' but 'show me the goods.' And that’s precisely what Eric J. Dalton has done. The Vice President at Angels on Call Homecare isn't just tooting his own horn; he's building a damn symphony in the...
Continue Reading
LG Energy Sparks Global Innovation with BIC 2026
Innovating Beyond Boundaries with LG Energy The world of battery tech is on fire, and LG Energy Solution is fanning the flames with their Battery Innovation Contest 2026 (BIC 2026). From October 29 to December 6, 2026, universities and research hives across the globe are being beckoned to pour their battery brilliance into this contest. These aren't just any research...
Continue Reading
Clip Expands Horizons with Pulpos Acquisition, New Board Member
Clip's Strategic Move with Pulpos Clip just laid down a serious marker in the digital payment world by snagging Pulpos, a firm that’s got its claws deep into AI-driven business management software. This move isn't just some fancy headline. It's a real, grounded step in expanding Clip's ecosystem to bolster the backbone of Mexico's economy: small and medium-sized...
Continue Reading
Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital
There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....
Continue Reading
Honeywell Aerospace Posts Solid Q3, Raises Guidance
Honeywell Aerospace Surprises with Strong Third Quarter In a world where numbers are often as slippery as a greased pig, Honeywell Aerospace (NASDAQ:HONA) has managed to pin down a surprisingly robust third quarter. Let’s break it down: they’ve claimed sales of a cool $4.6 billion, reflecting a 2% bump both in reported and organic revenue from the previous year, and...
Continue Reading
Oracle's Bold Vision: Targeting $225B Revenue by 2030
Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...
Continue Reading
2026 Global Ocean Forum Unveils Key Marine Strategies
Riding the Waves in Qingdao It ain't every day that a talk-fest dedicated to oceans gets my attention, but when the Global Ocean Development Forum plants its flag in Qingdao, even I sit up. We're talking about some real fireworks in the marine economy sector with this gig's '1+1+4+8' framework. Now, before you scratch your head on the bingo numbers—it's the opening...
Continue Reading
TransCode Pursues Strategic Moves for TTX-MC138 Value
A New Chapter for TransCode? Every once in a while, you find companies taking bold steps that make the market look twice. Today, that’s TransCode Therapeutics (NASDAQ: RNAZ) putting their chips on the table, determined to find the best route forward for their oncology efforts. Now, I’ve seen outfits talk plans without substance, but getting Tungsten Advisors on board...
Continue Reading
Firehawk Defense Secures $150M, Valuation Hits $1.4B
Firehawk Defense Lands Major Funding Think about it—Firehawk Defense, a gutsy Dallas-based new-kid-on-the-block, just snagged a whopping $150 million in fresh funding. The news? Their valuation's now sitting pretty at $1.4 billion. Not peanuts, by any means. For a company in the artillery game, that's a blast of an announcement. They're predicting they'll become the big...
Continue Reading
Step into Fear: Dead by Daylight in Moreno Valley
Immersive Horror in Moreno Valley Walking straight into the fog of your nightmares isn't for the faint-hearted, but that's the kind of thrill the Moreno Valley Museum & ArtSpace is serving up with its new Dead by Daylight Immersive Experience. Kicking off just in time for Halloween on October 30, this isn't your average stroll in a museum—it's a heart-pounding,...
Continue ReadingTop 5 Most Recently Viewed Articles
Elevate Your Cooking with Epicurean's A.1. Steakhouse Butter
Epicurean Butter Expands Offerings with New A.1. Steakhouse Butter Epicurean Butter, a brand recognized for its commitment to quality and exceptional flavor, has recently introduced a game-changing product for home cooks: A.1. Steakhouse Butter. Created in partnership with Kraft Heinz, this innovative butter is now available at select grocery stores in Texas, making it...
Continue Reading
Alex Vari Appointed CFO at MainStreet Bank, A Strong Move
MainStreet Bank Names Alex Vari as Chief Financial Officer In a significant internal promotion, MainStreet Bancshares, Inc. has announced that Alex Vari is stepping up as the Executive Vice President and Chief Financial Officer (CFO) of MainStreet Bank. This appointment underscores the bank's commitment to fostering strong leadership from within its ranks. Acknowledgment...
Continue Reading
The Impact of AI on Customer Discovery and Lead Generation
The Transformative Role of AI in Customer Discovery AI-powered tools are radically changing how customers find and interact with businesses. A recent analysis by CallRail reveals that large language models (LLMs) like ChatGPT are influencing customer choices considerably. The findings indicate that AI tools are not just enhancing the customer experience but are reshaping...
Continue Reading
Project InnerSpace: Leading the Charge for Geothermal Growth
Project InnerSpace Revolutionizes Geothermal Energy Funding Project InnerSpace (InnerSpace) has emerged as a frontrunner in the geothermal energy sector, now recognized as the largest independent nonprofit organization funding next-generation geothermal initiatives globally. Despite achieving $16.6 million in research investments, the organization is not celebrating just...
Continue Reading
How Jay Powell's Decisions Impact Tax-Free Municipal Bonds
How Jay Powell's Recent Moves Affect Municipal Bonds During a quiet holiday break, many were intrigued to learn about how Jay Powell’s recent adjustments could potentially ignite interest in high-yielding, tax-free municipal bonds. Recently, Powell made a quarter-point rate cut, yet simultaneously delivered a warning to investors, revising the Federal Reserve’s...
Continue Reading